Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 650x80px
Organisation › Details

Kinnate Biopharma Inc.

Kinnate Biopharma, Inc. is a precision oncology company advancing a pipeline of therapeutics to treat patients with genomically defined vulnerabilities. Kinnate’s focus is on the design and development of selective small molecules with the mission to provide the right drug to the right patient. Headquartered in San Diego, CA, the Kinnate team comprises oncology experts, each with decades of experience developing small molecule therapies. *


Period Start 2018-04-01 established
Products Industry kinase inhibitor
  Industry 2 drug development
Region Region San Diego, CA
  Country United States (USA)
  Street 11975 El Camino Real
Suite 101
  City 92130 San Diego, CA
    Address record changed: 2020-01-03
Basic data Employees n. a.
    * Document for �About Section�: NorthSea Therapeutics B.V.. (1/8/20). "Press Release: NorthSea Therapeutics Announces US $40 Million Series B Financing to Complete Phase IIb ICONA Study in NASH and to Advance Two Additional SEFAs into the Clinic". Naarden.
Record changed: 2020-01-03


Picture Kentro Design Corporate and Web Design Berlin 650x65px

More documents for Kinnate Biopharma Inc.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BIO-Europe Spring 2020 Paris BEU2020 650x75

» top